UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The economic burden of caregiving in epilepsy: An estimate based on a survey of US caregivers

Epilepsia (Copenhagen), 2020-02, Vol.61 (2), p.319-329

2020

Volltextzugriff (PDF)

Corrigendum to “Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia” [Leuk. Res. (2022) 106946]

Leukemia research, 2024-01, Vol.136, p.107430-107430, Article 107430

2024

Volltextzugriff (PDF)

Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia

Leukemia research, 2022-11, Vol.122, p.106946, Article 106946

2022

Volltextzugriff (PDF)

Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy

Future oncology (London, England), 2022-10, Vol.18 (32), p.3609-3621

2022

Volltextzugriff (PDF)

Real‐world analysis of hospitalizations in patients with epilepsy and treated with perampanel

Epilepsia open, 2021-12, Vol.6 (4), p.645-652

2021

Volltextzugriff (PDF)

Risk of hospitalization among patients with epilepsy using long versus short half-life adjunctive antiepileptic drugs

Epilepsy & behavior, 2020-01, Vol.102, p.106634-106634, Article 106634

2020

Volltextzugriff (PDF)

Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients' Perspective

Journal of clinical medicine, 2023-01, Vol.12 (2), p.414

2023

Volltextzugriff (PDF)

Observational study of clinical outcomes of eribulin mesylate in metastatic breast cancer after cyclin-dependent kinase 4/6 inhibitor therapy

Future oncology (London, England), 2019-12, Vol.15 (34), p.3935-3944

2019

Volltextzugriff (PDF)

Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs

Value in health, 2017-02, Vol.20 (2), p.200-205

2017

Volltextzugriff (PDF)

Effect of inadequate response to treatment in patients with depression

The American journal of managed care, 2010-08, Vol.16 (8), p.e188-e196

2010

Volltextzugriff (PDF)

Examining Hospital Utilization and Costs Following Rufinamide Treatment in Children with Intractable Seizures and Developmental Disorders (P3.206)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy

Blood, 2021-11, Vol.138 (Supplement 1), p.4039-4039

2021

Volltextzugriff (PDF)

Annual Healthcare Resource Utilization and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia

Blood, 2020-11, Vol.136 (Supplement 1), p.13-14

2020

Volltextzugriff (PDF)

Real-World Use of Enasidenib in Relapsed or Refractory Acute Myeloid Leukemia Is Associated with Reduced Risk of Disease Progression and Death

Blood, 2020-11, Vol.136 (Supplement 1), p.18-18

2020

Volltextzugriff (PDF)

Healthcare Resource Utilization Among Persons with Epilepsy Treated by Different Healthcare Providers (P2.001)

Neurology, 2016-04, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

Healthcare Resource Utilization Among Persons with Epilepsy Treated by Different Healthcare Providers (I14.006)

Neurology, 2016-04, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

Understanding the Association between Red Blood Cell Transfusion Dependency and Humanistic, Psychosocial, and Psychological Burden in Patients with β-Thalassemia from the Patients' Perspective

Blood, 2021-11, Vol.138 (Supplement 1), p.4062-4062

2021

Volltextzugriff (PDF)

Time and Side-Effect Burden Associated with Red Blood Cell Transfusions in Patients Diagnosed with Transfusion-Dependent β-Thalassemia

Blood, 2021-11, Vol.138 (Supplement 1), p.4987-4987

2021

Volltextzugriff (PDF)

Abstract P456: Examining Framingham Coronary Heart Disease 10-year Risk Reduction in Individuals Treated With Lorcaserin, a Selective 5HT 2C Receptor Agonist for Weight Management

Hypertension (Dallas, Tex. 1979), 2017-09, Vol.70 (suppl_1)

2017

Volltextzugriff (PDF)

Costs associated with the treatment of patients with bipolar disorder in a managed care organization

Psychiatric services (Washington, D.C.), 2004-12, Vol.55 (12)

2004

Volltextzugriff (PDF)

Inpatient Hospitalization Rates in Patients Diagnosed with Epilepsy and Treated with Perampanel or Lacosamide (P3.5-018)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Risk of Hospitalization in Patients With Uncontrolled Epilepsy Treated with a Long Versus Short Half-Life Adjunctive Antiepileptic Medication (P3.5-002)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Inpatient Hospitalization Risk In Patients With Epilepsy Before And After Perampanel Treatment (P3.5-022)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Measurement of the conjunction error in social judgment: Answer choice and answer justification

Social behavior and personality, 2009-05, Vol.37 (4), p.481-490

2009

Volltextzugriff (PDF)

Datapoints: Costs Associated With the Treatment of Patients With Bipolar Disorder in a Managed Care Organization

Psychiatric services (Washington, D.C.), 2004-12, Vol.55 (12), p.1353-1353

2004

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The economic burden of caregiving in epilepsy: An estimate based on a survey of US caregivers

Corrigendum to “Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia” [Leuk. Res. (2022) 106946]

Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia

Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy

Real‐world analysis of hospitalizations in patients with epilepsy and treated with perampanel

Risk of hospitalization among patients with epilepsy using long versus short half-life adjunctive antiepileptic drugs

Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients' Perspective

Observational study of clinical outcomes of eribulin mesylate in metastatic breast cancer after cyclin-dependent kinase 4/6 inhibitor therapy

Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs

Effect of inadequate response to treatment in patients with depression

Examining Hospital Utilization and Costs Following Rufinamide Treatment in Children with Intractable Seizures and Developmental Disorders (P3.206)

Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy

Annual Healthcare Resource Utilization and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia

Real-World Use of Enasidenib in Relapsed or Refractory Acute Myeloid Leukemia Is Associated with Reduced Risk of Disease Progression and Death

Healthcare Resource Utilization Among Persons with Epilepsy Treated by Different Healthcare Providers (P2.001)

Healthcare Resource Utilization Among Persons with Epilepsy Treated by Different Healthcare Providers (I14.006)

Understanding the Association between Red Blood Cell Transfusion Dependency and Humanistic, Psychosocial, and Psychological Burden in Patients with β-Thalassemia from the Patients' Perspective

Time and Side-Effect Burden Associated with Red Blood Cell Transfusions in Patients Diagnosed with Transfusion-Dependent β-Thalassemia

Abstract P456: Examining Framingham Coronary Heart Disease 10-year Risk Reduction in Individuals Treated With Lorcaserin, a Selective 5HT 2C Receptor Agonist for Weight Management

Costs associated with the treatment of patients with bipolar disorder in a managed care organization

Inpatient Hospitalization Rates in Patients Diagnosed with Epilepsy and Treated with Perampanel or Lacosamide (P3.5-018)

Risk of Hospitalization in Patients With Uncontrolled Epilepsy Treated with a Long Versus Short Half-Life Adjunctive Antiepileptic Medication (P3.5-002)

Inpatient Hospitalization Risk In Patients With Epilepsy Before And After Perampanel Treatment (P3.5-022)

Measurement of the conjunction error in social judgment: Answer choice and answer justification

Datapoints: Costs Associated With the Treatment of Patients With Bipolar Disorder in a Managed Care Organization

Suchergebnisse filtern